title: Monitoring of minimal residual disease after allografting: a requirement to guide DLI treatment?
authors.affiliation: Dept of Haematology, Imperial College Faculty of Medicine, Hammersmith Campus, London, UK.
authors.forename: F
authors.initials: F
authors.lastname: Dazzi
mesh_terms: D001782:Blood Donors; D006086:Graft vs Host Disease; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D017710:Lymphocyte Transfusion; D018365:Neoplasm, Residual / Q000175:diagnosis*; D012074:Remission Induction; D033581:Stem Cell Transplantation; D014184:Transplantation, Homologous